International Patent: 5T4 ANTIBODY DRUG CONJUGATES AND METHODS OF THEIR USE

GENEVA, Sept. 18 -- EXELIXIS, INC. filed a patent application (US2026/017995) for “5T4 ANTIBODY DRUG CONJUGATES AND METHODS OF THEIR USE”. With publication no. WO/2026/188090, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 47/68

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....